Literature DB >> 15940371

Predictive value of BMD for hip and other fractures.

Olof Johnell1, John A Kanis, Anders Oden, Helena Johansson, Chris De Laet, Pierre Delmas, John A Eisman, Seiko Fujiwara, Heikki Kroger, Dan Mellstrom, Pierre J Meunier, L Joseph Melton, Terry O'Neill, Huibert Pols, Jonathan Reeve, Alan Silman, Alan Tenenhouse.   

Abstract

UNLABELLED: The relationship between BMD and fracture risk was estimated in a meta-analysis of data from 12 cohort studies of approximately 39,000 men and women. Low hip BMD was an important predictor of fracture risk. The prediction of hip fracture with hip BMD also depended on age and z score.
INTRODUCTION: The aim of this study was to quantify the relationship between BMD and fracture risk and examine the effect of age, sex, time since measurement, and initial BMD value.
MATERIALS AND METHODS: We studied 9891 men and 29,082 women from 12 cohorts comprising EVOS/EPOS, EPIDOS, OFELY, CaMos, Rochester, Sheffield, Rotterdam, Kuopio, DOES, Hiroshima, and 2 cohorts from Gothenburg. Cohorts were followed for up to 16.3 years and a total of 168,366 person-years. The effect of BMD on fracture risk was examined using a Poisson model in each cohort and each sex separately. Results of the different studies were then merged using weighted coefficients.
RESULTS: BMD measurement at the femoral neck with DXA was a strong predictor of hip fractures both in men and women with a similar predictive ability. At the age of 65 years, risk ratio increased by 2.94 (95% CI = 2.02-4.27) in men and by 2.88 (95% CI = 2.31-3.59) in women for each SD decrease in BMD. However, the effect was dependent on age, with a significantly higher gradient of risk at age 50 years than at age 80 years. Although the gradient of hip fracture risk decreased with age, the absolute risk still rose markedly with age. For any fracture and for any osteoporotic fracture, the gradient of risk was lower than for hip fractures. At the age of 65 years, the risk of osteoporotic fractures increased in men by 1.41 per SD decrease in BMD (95% CI = 1.33-1.51) and in women by 1.38 per SD (95% CI = 1.28-1.48). In contrast with hip fracture risk, the gradient of risk increased with age. For the prediction of any osteoporotic fracture (and any fracture), there was a higher gradient of risk the lower the BMD. At a z score of -4 SD, the risk gradient was 2.10 per SD (95% CI = 1.63-2.71) and at a z score of -1 SD, the risk was 1.73 per SD (95% CI = 1.59-1.89) in men and women combined. A similar but less pronounced and nonsignificant effect was observed for hip fractures. Data for ultrasound and peripheral measurements were available from three cohorts. The predictive ability of these devices was somewhat less than that of DXA measurements at the femoral neck by age, sex, and BMD value.
CONCLUSIONS: We conclude that BMD is a risk factor for fracture of substantial importance and is similar in both sexes. Its validation on an international basis permits its use in case finding strategies. Its use should, however, take account of the variations in predictive value with age and BMD.

Entities:  

Mesh:

Year:  2005        PMID: 15940371     DOI: 10.1359/JBMR.050304

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  480 in total

1.  Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes.

Authors:  Ann V Schwartz; Eric Vittinghoff; Douglas C Bauer; Teresa A Hillier; Elsa S Strotmeyer; Kristine E Ensrud; Meghan G Donaldson; Jane A Cauley; Tamara B Harris; Annemarie Koster; Catherine R Womack; Lisa Palermo; Dennis M Black
Journal:  JAMA       Date:  2011-06-01       Impact factor: 56.272

2.  Identification of quantitative trait loci influencing skeletal architecture in mice: emergence of Cdh11 as a primary candidate gene regulating femoral morphology.

Authors:  Charles R Farber; Scott A Kelly; Ethan Baruch; Daniel Yu; Kunjie Hua; Derrick L Nehrenberg; Fernando Pardo-Manuel de Villena; Ryan J Buus; Theodore Garland; Daniel Pomp
Journal:  J Bone Miner Res       Date:  2011-09       Impact factor: 6.741

3.  Diabetes and femoral neck strength: findings from the Hip Strength Across the Menopausal Transition Study.

Authors:  Shinya Ishii; Jane A Cauley; Carolyn J Crandall; Preethi Srikanthan; Gail A Greendale; Mei-Hua Huang; Michelle E Danielson; Arun S Karlamangla
Journal:  J Clin Endocrinol Metab       Date:  2011-11-09       Impact factor: 5.958

Review 4.  Whole bone mechanics and bone quality.

Authors:  Jacqueline H Cole; Marjolein C H van der Meulen
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

5.  International variation in proximal femur bone mineral density.

Authors:  M A Paggiosi; C C Glueer; C Roux; D M Reid; D Felsenberg; R Barkmann; R Eastell
Journal:  Osteoporos Int       Date:  2010-07-15       Impact factor: 4.507

6.  A poisson process model for hip fracture risk.

Authors:  Zvi Schechner; Gangming Luo; Jonathan J Kaufman; Robert S Siffert
Journal:  Med Biol Eng Comput       Date:  2010-06-04       Impact factor: 2.602

Review 7.  Genetic profiling and individualized assessment of fracture risk.

Authors:  Tuan V Nguyen; John A Eisman
Journal:  Nat Rev Endocrinol       Date:  2013-02-05       Impact factor: 43.330

8.  Osteoporosis practice patterns in 2006 among primary care physicians participating in the NORA study.

Authors:  T W Weiss; E S Siris; E Barrett-Connor; P D Miller; C A McHorney
Journal:  Osteoporos Int       Date:  2007-06-19       Impact factor: 4.507

9.  Multisystem dysregulation and bone strength: findings from the study of midlife in the United States.

Authors:  Takahiro Mori; Arun S Karlamangla; Sharon Stein Merkin; Carolyn J Crandall; Neil Binkley; Gail A Greendale; Teresa E Seeman
Journal:  J Clin Endocrinol Metab       Date:  2014-02-14       Impact factor: 5.958

10.  The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease.

Authors:  J Aleksova; S Kurniawan; G J Elder
Journal:  Osteoporos Int       Date:  2018-03-19       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.